According to a new report, published by KBV research, The Global Home Healthcare Market size is expected to reach $405.6 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.
The Services market is leading the segment in the Global Home Healthcare Market by Type in 2021; thereby, achieving a market value of $329.3 billion by 2028. This is due to the rising number of old aged population who are not capable enough to go for medical treatments in hospitals. In addition, there is rising demand for healthcare services among people with high income as they could afford expensive healthcare in sake of protecting themselves from getting infected by visiting hospitals.
The Diabetes market is exhibiting a CAGR of 8.4% during (2022 - 2028). Home health care may assist a person with type 2 diabetes in managing their disease and can also aid with other medical issues. If patients need someone to visit them at home to help them with activities like taking daily medications or doing other regular duties, it could be a useful option for them.
The North America market dominated the Global Home Healthcare Market by Region in 2021; thereby, achieving a market value of $147.9 billion by 2028. The Asia Pacific market is poised to grow at a CAGR of 9.3% during (2022 - 2028). Additionally, The Europe market would witness a CAGR of 8.1% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/home-healthcare-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.
By Type
By Indication
By Geography
Companies Profiled